InteraXon Inc. et al v. Neurotek, LLC et al

Filing 135

ORDER by Judge Kandis A. Westmore Regarding 127 130 Discovery Letter Briefs. (kawlc2, COURT STAFF) (Filed on 9/21/2016)

Download PDF
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 INTERAXON INC., et al., Case No. 15-cv-05290-KAW Plaintiffs, 8 v. ORDER REGARDING DISCOVERY LETTER BRIEFS 9 10 NEUROTEK, LLC, et al., Re: Dkt. Nos. 127, 130 Defendants. United States District Court Northern District of California 11 12 13 Currently pending before the Court are Plaintiff InteraXon's discovery letter brief and 14 Defendant Jonathan Cowan's response. (Dkt. Nos. 127, 130.) The Court deems the matter 15 suitable for disposition without a hearing pursuant to Civil Local Rule 7-1(b). Having reviewed 16 the papers filed by the parties and the relevant legal authority, the Court resolves the parties' 17 discovery disputes as set forth below. 18 19 I. BACKGROUND Plaintiffs InteraXon and InteraXon U.S., Inc. (collectively, "InteraXon") filed this suit 20 against Defendants NeuroTek, LLC, MindWaves, Ltd., and Dr. Jonathan D. Cowan (collectively, 21 "Defendants") on November 18, 2015, seeking a declaration of non-infringement and a declaration 22 of invalidity as to Patent No. 5,983,129 ("'129 Patent"). (Compl., Dkt. No. 1.) InteraXon 23 manufactures the MUSE Headband. (Compl. ¶ 4.) Around October 2013, Defendants accused 24 InteraXon of infringing on the '129 Patent, and offered to license it. (Compl. ¶ 29.) In November 25 2014, Defendants demanded that InteraXon "cease and desist" from infringing on the '129 Patent, 26 or enter into a licensing agreement. (Compl. ¶ 30.) The parties began negotiations for a license, 27 during which Defendants withdrew the cease and desist demand, but InteraXon alleges that 28 Defendants threatened to reinstate that demand around May 2015. (Compl. ¶ 32.) InteraXon then 1 filed the instant suit. Cowan has filed a counterclaim for infringement on the '129 Patent. 2 (Answer, Dkt. No. 63 ¶ 45.) 3 4 II. DISCUSSION The parties' letters concern Cowan's Infringement Contentions, as required by Patent Local Rule 3-1. Patent Local Rule 3-1 "governs the disclosure of asserted claims and infringement 6 contentions ('ICs')." Shared Memory Graphics LLC v. Apple, Inc., 812 F. Supp. 2d 1022, 1024 7 (N.D. Cal. 2010). It requires the party asserting infringement to: "(a) identify each claim that is 8 being infringed; (b) identify each accused product for each claim; (c) provide a chart identifying 9 specifically where each limitation of each asserted claim is found in each accused product; and (d) 10 specify whether infringement is literal or based on the doctrine of equivalents." Id.; see also Pat. 11 United States District Court Northern District of California 5 L.R. 3-1. To satisfy the rule, the party asserting infringement "is required to include in its 12 infringement contentions all facts known to it, including those discovered in its pre-filing inquiry." 13 Id. Further, the specificity required by Rule 3-1 "must be sufficient to provide reasonable notice 14 to the defendant why the plaintiff believes it has a reasonable chance of proving infringement," 15 and "to raise a reasonable inference that all accused products infringe." Id. at 1025 (internal 16 quotations omitted). Thus, a patent holder "must map specific elements of [the] alleged infringing 17 products onto the Plaintiff's claim construction." Id. 18 First, Plaintiffs contend that Cowan has failed to provide a meaningful claim chart 19 identifying where each limitation of each asserted claim is found within the accused infringing 20 product. (Dkt. No. 127 at 2.) Cowan responds that he needs more information to comply, and 21 seeks to complete all discovery before being required to modify his ICs. (Dkt. No. 130 at 2, 5.) 22 Having reviewed the ICs, the Court finds that the ICs are not in compliance with Rule 3-1 as they 23 fail to specify where the various components and software functions are found. Compare with 24 Shared Memory Graphics, 812 F. Supp. 2d at 1025-26 (finding sufficient specificity where the 25 plaintiff identified specific chips which constituted particular elements of a claim, but that other 26 contentions were too vague because they failed to specifically identify which structures constitute 27 the display data distribution bus); contrast with Case No. C-14-775 EMC, Grecia v. Apple Inc., 28 2015 WL 81893, at *2 (N.D. Cal. Jan. 5, 2015) (finding adequate ICs where the plaintiff defined 2 what the metadata was and its form, identified specific locations in the accused system that 2 practiced the infringing steps of reading from and writing into the metadata (including exemplar 3 screenshots), and explained how the read and write requests were made (including screenshots 4 with detailed labels showing how the system prompts and confirms requests)). Further, it is 5 insufficient to state that the location is "a combination of the answers to 1A-E" as this requires 6 Plaintiffs to guess as to what this "combination" is. See Finjan, Inc. v. Proofpoint, Inc., Case No. 7 13-cv-5808-HSG, 2015 WL 1517920, at *7 (N.D. Cal. Apr. 2, 2015) ("At a minimum, Finjan was 8 required to expressly discuss the particular claim elements in each Claim and map those elements 9 onto the features of the allegedly infringing products. . . . Neither the Court nor the Defendants 10 should be required to guess which aspects of the accused products allegedly infringe each claim 11 United States District Court Northern District of California 1 element."). Cowan also provides no documentation in support of his theory of infringement, as 12 required by Patent Local Rule 3-2. As such, Cowan's ICs are inadequate. 13 Second, Plaintiffs argue that Cowan cannot assert the doctrine of equivalents without 14 explaining why or how it applies. (Dkt. No. 127 at 4-5.) Cowan does not respond. The Court 15 agrees that Cowan must describe his bases for asserting the doctrine of equivalents; otherwise, 16 "[i]f a plaintiff does not have a factual basis to asset the doctrine of equivalents in its infringement 17 contentions at that time, it should not do so. It is improper to assert the doctrine of equivalents 18 with generic 'placeholder' language on the hope that future discovery might support such an 19 assertion." Finjan, 2015 WL 15174920, at *10. In any case, if Cowan should later find, through 20 discovery, sufficient evidence in support of this theory, Cowan can move the Court to amend his 21 infringement contentions pursuant to Patent Local Rule 3-6 upon a showing of good cause. See id. 22 Therefore, in his revised ICs, Cowan must provide a basis for the doctrine of equivalents or the 23 Court will strike the language asserting the doctrine of equivalents. 24 Finally, Plaintiffs challenge Cowan's failure to provide a chart or documentation with 25 respect to the accused products other than the InteraXon Muse, which Cowan contends is the 26 principal infringing product. (Dkt. No. 127 at 5; see also Cowan's Initial Patent Disclosures 27 Revision 1A, Dkt. No. 127, Exh. 3 at 2.) Cowan again does not respond. In general, "a separate 28 claim chart for each accused product is not mandatory under Patent Local Rule 3-1(c)." Finjan, 3 1 2015 WL 15174920, at *3. A combination chart is permissible "if each accused product allegedly 2 infringes in the same way." Id. Here, the additional accused products cannot possibly infringe in 3 the same way as the InteraXon Muse; Cowan himself describes the additional products as 4 "specialized software for developers . . . which they can use to create and sell adaptions of the 5 Muse software," while the InteraXon Muse is a physical product. (Cowan's Initial Patent 6 Disclosures Revision 1A at 2.) Cowan's chart then explains that Claim 1A takes place in the EEG 7 sensors attached to the Muse's band, a location that would not exist in the software products. (See 8 id. at 3.) The InteraXon Muse and the software products are not functionally identical and there is 9 no showing that they infringe on each claim in the same way. While Cowan may be able to provide a single chart for the software products (assuming Cowan makes an adequate showing that 11 United States District Court Northern District of California 10 the software products are functionally identical and infringe Patent '129 in the same way), he 12 cannot use a single chart for both the InteraXon Muse and the software products. 13 III. CONCLUSION 14 For the reasons stated above, the Court finds that Cowan's ICs are inadequate and not in 15 compliance with the Patent Local Rules. Cowan is to provide revised ICs within 14 days of the 16 date of this Order. Until Cowan serves ICs that are compliant with the Patent Local Rules, the 17 Court will not permit Cowan to seek discovery from InteraXon. The Court denies Cowan's 18 request for sanctions and additional discovery. 19 20 IT IS SO ORDERED. Dated: September 21, 2016 __________________________________ KANDIS A. WESTMORE United States Magistrate Judge 21 22 23 24 25 26 27 28 4

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?